MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech's Big Market Movers (Nanobiotix)


Nanobiotix wants to transform therapy using its NanoXray technology portfolio. When certain nanoparticles are directly injected into cancerous tissue and radiotherapy is applied, these particles have the ability to absorb x-rays and increase the amount of radiation to destroy diseased cells. Surrounding healthy tissue do not get increased radiation doses. 

Last year, the French company's share price jumped 217%, to 16.72 euros ($18.38) from 5.27 euros ($6.85) at the end of 2013. As a result, the company added $221 million to its market cap.

TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.